Mayflower Financial Advisors, LLC Amgen Inc Transaction History

Mayflower Financial Advisors, LLC

$638 Million
Q4 2024

A detailed history of Mayflower Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mayflower Financial Advisors, LLC holds 3,843 shares of AMGN stock, worth $1.1 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

3,843

Previous 4,125 6.84%

Holding current value

$1.1 Million

Previous $1.33 Million 24.68%

% of portfolio

0.16%

Previous 0.21%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$258.78 - $328.31 $72,975 - $92,583	-282 Reduced 6.84%	3,843 $1 Million
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $1,856 - $2,024	-6 Reduced 0.15%	4,125 $1.33 Million
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $60,958 - $74,079	232 Added 5.95%	4,131 $1.29 Million
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $31,726 - $38,298	118 Added 3.12%	3,899 $1.11 Million
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $20,200 - $22,788	-79 Reduced 2.05%	3,781 $1.09 Million
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $97,955 - $121,614	-448 Reduced 10.4%	3,860 $1.04 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $428 - $506	-2 Reduced 0.05%	4,308 $956,000
Q1 2023 Apr 12, 2023	BUY	$225.79 - $275.2 $219,693 - $267,769	973 Added 29.16%	4,310 $1.04 Million
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $764,273 - $971,100	3,337 New	3,337 $0
Q3 2022 Oct 19, 2022	SELL	$224.46 - $253.15 $443,757 - $500,477	-1,977 Reduced 30.13%	4,585 $1.03 Million
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $441,288 - $497,692	1,966 Added 42.78%	6,562 $1.48 Million
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $5,998 - $6,675	26 Added 0.57%	4,596 $1.12 Million
Q1 2022 Apr 21, 2022	SELL	$219.27 - $242.57 $19,295 - $21,346	-88 Reduced 1.89%	4,570 $1.11 Million
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $142,398 - $162,961	-716 Reduced 13.32%	4,658 $1.05 Million
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $177,033 - $207,415	-834 Reduced 13.43%	5,374 $1.11 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $185,228 - $205,498	793 Added 14.64%	6,208 $1.51 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $163,991 - $191,105	739 Added 15.8%	5,415 $1.35 Million
Q4 2020 Apr 12, 2021	BUY	$216.38 - $257.67 $1.01 Million - $1.2 Million	4,676 New	4,676 $1.08 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.

Account

Mayflower Financial Advisors, LLC Amgen Inc Transaction History